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Introduction
The detection of TSH receptor (TRAb) and/or thyroidstimulating antibody (TSAb) has been reported in some patients with Graves' disease (1, 2) or hypothyroidism (3, 4) after subacute thyroiditis (SAT). Tamai et al reported that the frequencies of TRAband TSAbwere higher in patients with SATwho developed transient hypothyroidism than in patients who did not (3) . This suggests that TRAband especially TSAbare related to the thyroid damage, which causes the hypothyroid state that occurs during the course of SAT.
On the other hand, in SAT, 99mTc uptake has been known to be markedly diminished (5) . In recent years, reports of elevated 99mTcuptake and detection of TRAband TSAbin the course of SAThave been published (6) . A case has also been reported with a possible association between SAT and Graves' disease (7).
Thirty-two patients showed high titers of TRAband TSAb during the acute thyrotoxic phase of SATand four of them had high thyroidal RAIUor 99mTc uptake (7) (8) (9) (10) (11) (12) . Histological examination of the thyroid gland, however, was reported in only three patients (7, 10) . Out of the three reported cases, the histological examination indicated SAT in only one of the patients, and a transient hypothyroid state did not occur during the clinical course (7) .
Weare interested in the meaning of the high TRAb and TSAb titers and high thyroidal RAIU during the course of SAT without subclinical hypothyroidism.
In the present paper, we report the case of a patient with SATwho did not exhibit transient subclinical hypothyroidism and investigate the histology of the thyroid gland and the changes in thyroidrelated antibodies including TRAb and TSAb during the course of the disease. The possible pathogenic mechanisms are also discussed.
Case Report
On May1, 1997, a 48-year-old womancame to our clinic complaining of a high fever (38°C), severe neck and shoulder pain, palpitation, hyperhydrosis, body weight loss (4 kg), and finger tremors for the previous 2 weeks. Three weeks before, she had suffered from an upper respiratory tract infection. At age 43 years, she was diagnosed as having right thyroid follicular adenoma by a thyroid aspiration biopsy at another hospital. At that time, the levels of serum thyroid hormones were normal, and the level of serum TRAbwas not measured. Examination revealed a fever (38.4°C), moist SAT with Positive TRAb and Slightly High RAIU skin, tachycardia (120 b.p.m.) and a diffuse large goiter with spontaneous pain (right lobe 6x2 cm, left lobe 5x1.5 cm; very severe tenderness in the right lobe), but there were no signs of Graves' ophthalmopathy. (3.9% at 20 m; normal range 0.4-3.0% at 20 m) with partially low uptake in the right lobe were observed on May 2 (Fig. 1A) . Histological examination of needle biopsy specimens obtained from bilateral lobes showed the coexistence of extensive cellular destruction with marked interstitial fibrosis and infiltration with small lymphocytes and macrophages (granulomatous inflammatory changes) (Fig. 2 ).
Since the thyrotoxicosis was considered to be due to SAT, a 30 mg daily dose of prednisolone was initiated on May10.
The following day, the fever and painful tenderness in the right lobe disappeared. During the course of reducing the (201%) and unsuppressed 99mTc uptake (2.7% at 20 m) without partially low uptake was observed (Fig. 1C) . The levels of fT4 (0.94 ng/dl), and fT3 (4.64 pg/ml) were also within normal range, and the level of TSH (<0.01 mIU/0 had been suppressed. By December ll, 1997, the serum level of TSH had returned to under the normal (0.29 mIU/7), because the level of TRAb(20.6%) was still above normal range. After that, the levels of TRAb and TSAb finally normalized to 5.6% and 140%, respectively, on February 5, 1998, and her serum levels of fT4, fT3, and TSH remained normal for the subsequent 9 months (Fig. 3 , Table 1 ). The serum titers of antibodies to adenovirus, Epstein-Barr virus, coxsackievirus, influenza, mumps, measles, and parainfluenza were negative. She was positive for HLAA 2, A 24,A25,B35,B48,B61,Cw3,DR4,DR12,DQ3,DQ 4. 
Discussion
A diagnosis of subacute thyroiditis was made after evaluation of the physical examination, clinical course, HLA-B35 (a genetic marker of SATin some patients) and histological examination, but there were two discrepancies. The first is that thyroidal 99mTcuptake in the thyrotoxic phase was not suppressed, and the second is that her serum levels of TRAb and TSAb (although not markedly high) were high for about 9 months. It is generally known that thyroidal 123I radioactive iodine uptake (RAIU) is low in SAT because thyroidal follicles are destroyed and the serum level of TSH,which is suppressed by high serum levels of thyroid hormones, is low. First, the inflammatory process was localized in a single lobe. In the second phase of SAT, 1-2 months after onset, an unusually high incidence (56%) of subclinical hypothyroidism was diagnosed using a TRHtest (13) . In our case, however, the maximal TSHvalue from the TRHtest was low by the hypersensitive method, meaning that the slightly high or normal thyroid uptake may not have been related to the serum TSHlevel. It is possible that the inflammatory process was localized in a single lobe during the early phase of SAT, but it is a very rare case (14, 15) . Second, the pathological mechanism of this case seems like neonatal Graves' disease. Neonatal Graves' disease is probably the best example of transient thyroid-stimulating antibody (TRAb and/or TSAb)-mediated thyrotoxicosis. In most infants, neonatal Graves' disease resolves spontaneously in 3 to 12 weeks as maternal TSAbdisappears from the serum of the infants. Furthermore, it is knownthat the titer of TRAb increases during 3 months following radioiodine therapy in patients with Graves' disease (16) . The situation after SATin terms of thyroid antigen release maybe quite similar to that of patients with Graves' disease after radioiodine therapy. In our case the serum TRAbhad presented and gradually decreased over about nine months, and there was no autonomousproduction of TRAb,which is the difference from Graves' disease's autonomic production of TRAb. Iitaka et al reviewed 1,697 patients with SAT for 10 years, but not all of the cases were examined histologically (12) . In their report, there were only five patients of hyperthyroidism with serum positive TRAbon their first visit, and only one patient' TRAb became negative spontaneously eight months later, and the TRAbtiter increased afterwards in the rest four hyperthyroid patients. The situations of the present case and only one of the patients they reported appear to be very similar, and further pathological examination for immunological abnormal production of the TRAbin the thyroid gland will be needed. Third, other thyroid RAIUstimulating factors may be present. In SAT, eicosanoids such as prostaglandins and cytokines such as interleukin-4
(IL-4) may be produced in the thyroid (17) , and are known to increase TSH-stimulated iodine uptake (18) . But this idea can be denied because of two reasons. One reason is that generally the thyroid RAIU in the thyrotoxic phase of SAT is low in spite of the high serum levels of prostaglandins and cytokines. Second is that in the present case, the thyroid RAIUwas slightly elevated for four months, the prostaglandines and cytokines from the destroyed thyroid gland had not been releasing for such a long period. The second possible pathological mechanism for this case is that this patient's disease was diagnosed as SAT associated with Graves' disease. There are two possibilities. First, the SATand Graves' disease occurred at the same time by viral infection or some autoimmune mechanism. 
